Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions

Experimental and Therapeutic Medicine

Volumn 9, Issue 3, 2015, Pages 913-918

  Ma, Zhen Shen ^a   Wang, Da Wei ^a   Sun, Xiu Bin ^b   Shi, Hao ^a   Pang, Tao ^a   Dong, Gui Qing ^a   Zhang, Cheng Qi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Breast lesions; Differential diagnosis; Dynamic contrast enhanced magnetic resonance imaging; Pathological grading; Vascular function parameters

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; BREAST LESION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EXTRAVASCULAR EXTRACELLULAR VOLUME FRACTION; FEMALE; HUMAN; IMAGE ANALYSIS; MATHEMATICAL PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RATE CONSTANT; VASCULAR FUNCTION PARAMETERS; VOLUME TRANSFER CONSTANT;

EID: 84922020958     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2154     Document Type: Article

References (31)

1. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS and Ioffe OB: Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233: 830-849, 2004.
2. Liberman L: Breast cancer screening with MRI - what are the data for patients at high risk? N Engl J Med 351: 497-500, 2004.
3. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
4. Weidner N, Folkman J, Pozza F, et al: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
5. DeVries A, Griebel J, et al: Perfusion-index values evaluated by dynamic magnetic resonance imaging in advanced rectal carcinoma. A new predictor of response to preoperative radiochemotherapy? Strahlenther Onkol 176: 567-572, 2000 (In German).
6. Kremer S, Grand S, Rémy C, et al: Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 46: 642-648, 2004.
7. Haris M, Gupta RK, Singh A, et al: Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI. Neuroradiology 50: 531-540, 2008.
8. Zhang H, Rödiger LA, et al: Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology 50: 525-530, 2008.
9. Pickles MD, Manton DJ, Lowry M and Turnbull LW: Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. Eur J Radiol 71: 498-505, 2009.
10. Kang TW, Kim ST, Byun HS, et al: Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol 72: 370-380, 2009.
11. Hauser T, Essig M, Jensen A, et al: Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters-preliminary results. Neuroradiology 55: 527-536, 2013.
12. Larsen VA, Simonsen HJ, Law I, Larsson HB and Hansen AE: Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology 55: 361-369, 2013.
13. Bäuerle T, Seyler L, Münter M, et al: Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: a comparative study with histology. Eur J Radiol 82: 444-452, 2013.
14. Jones EF, Sinha SP, Newitt DC, Klifa C, Kornak J, Park CC and Hylton NM: Mri enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy. PLoS One 8: e61969, 2013.
15. Li X, Arlinghaus LR, Ayers GD, et al: Dce-mri analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Magn Reson Med 71: 1592-1602, 2014.
16. Schnall MD, Blume J, Bluemke DA, DeAngelis GA, et al: Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238: 42-53, 2006.
17. Rykala J, Przybylowska K, Majsterek I, et al: Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables. Pathol Oncol Res 17: 809-817, 2011.
18. Medeiros LR, Duarte CS, Rosa DD, Edelweiss MI, et al: Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis. Breast Cancer Res Treat 126: 273-285, 2011.
19. Tofts PS, Brix G, Buckley DL, et al: Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted mri of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232, 1999.
20. Padhani AR and Husband JE: Dynamic contrast-enhanced mri studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 56: 607-620, 2001.
21. Preda A, van Vliet M, Krestin GP, Brasch RC and van Dijke CF: Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition. Invest Radiol 41: 325-331, 2006.
22. Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS and Choyke PL: Dynamic contrast-enhanced mri of prostate cancer at 3 t: a study of pharmacokinetic parameters. AJR Am J Roentgenol 189: 849-858, 2007.
23. Yao WW, Zhang H, Ding B, et al: Rectal cancer: 3d dynamic contrast-enhanced mri; correlation with microvascular density and clinicopathological features. Radiol med 116: 366-374, 2011.
24. Li X, Arlinghaus LR, Ayers GD, et al: dce-mri analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Magn Reson Med 71: 1592-1602, 2014.
25. Nilsen LB, Fangberget A, Geier OM, Engebraaten O, Borgen E, Olsen DR and Seierstad T: Associations between tumor vascularization assessed by in vivo dce-mri and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis. J Magn Reson Imaging Jan 27, 2014 (Epub ahead of print).
26. Jain RK: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62, 2005.
27. Tofts PS: Modeling tracer kinetics in dynamic gd-dtpa mr imaging. J Magn Reson Imaging 7: 91-101, 1997.
28. Wang Y, Huang W, Panicek DM, et al: Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data. Magn Reson Med 59: 1183-1189, 2008.
29. Koo HR, Cho N, Song IC, et al: Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers. J Magn Reson Imaging 36: 145-151, 2012.
30. Siegmann KC, Müller-Schimpfle M, Schick F, et al: Mr imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. Am J Roentgenol 178: 1403-1409, 2002.
31. Baek HM, Chen JH, Nie K, et al: Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using mr imaging and quantitative 1h mr spectroscopy. Radiology 251: 653-662, 2009.